Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma

Clinical Nuclear Medicine

Volumn 39, Issue 1, 2014, Pages 1-7

  Park, Tae Gyu ^a   Yu, Young Dong ^b   Park, Beom Jin ^b   Cheon, Gi Jeong ^a,c   Oh, Sun Young ^a   Kim, Dong Sik ^b   Choe, Jae Gol ^a  

^a Korea University   (South Korea)

^b Korea University Ansan Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

1 year recurrence; 18F FDG PET CT; Lymph node metastasis; Peripheral intrahepatic cholangiocarcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPROMIDE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMIHEPATECTOMY; HUMAN; LEFT MEDIAL SECTIONECTOMY; LIVER LOBECTOMY; LIVER RESECTION; LIVER SUV RATIO; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PET-CT SCANNER; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; RADIOLOGICAL PARAMETERS; RECURRENCE FREE SURVIVAL; RIGHT POSTERIOR SECTIONECTOMY; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR INVASION; WEDGE RESECTION;

AGED; CHOLANGIOCARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84891498269     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182867b99     Document Type: Article

References (18)

1. Choi SB, Kim KS, Choi JY, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: Association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol. 2009;16:3048-3056
2. Seo S, Hatano E, Higashi T, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Surgery. 2008;143:769-777
3. De Groen PC, Gores GJ, Larusso NF, et al. Biliary tract cancers. N Eng J Med. 1999;341:1368-1377
4. Han JK, Choi BI, Kim AY, et al. Cholangiocarcinoma: Pictorial essay of CT and cholangiographic findings. Radiographics. 2002;22:173-187
5. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Sur. 2002;183:679-685
6. Kato T, Tsukamoto E, Kuge Y, et al. Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med. 2002;29:1047-1054
7. Kubota K. From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology. Ann Nucl Med. 2001;15:471-486
8. Kim YJ, Yun MJ, Lee WJ, et al. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging. 2003;30:1467-1472
9. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: Characterization of tumor and assessment of effect of treatment. J Nucl Med. 1992;33:333-339
10. Messa C, Choi Y, Hoh CK, et al. Quantification of glucose utilization in liver metastases: Parametric imaging of FDG uptake with PET. J Comput Assist Tomogr. 1992;16:684-689
11. Shiomi S, Nishiguchi S, Ishizu H, et al. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol. 2001;96: 1877-1880
12. Oh SW, Kim SK. Clinical application of F-18 FDG PET in hepatocellular carcinoma. Nucl Med Mol Imaging. 2008;42:60-65
13. Miwa S, Miyagawa S, Kobayashi A, et al. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol. 2006;41:893-900
14. Cherqui D, Tantawi B, Alon R, et al. Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch Surg. 1995;130:1073-1078
15. Inoue K, Makuuchi M, Takayama T, et al. Long-Term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 2000;127:498-505
16. Feydy A, Vilgrain V, Enys A, et al. Helical CT assessment in hilar cholangiocarcinoma: Correlation with surgical and pathologic findings. Am J Roentgenol. 1999;172:73-77
17. Kim YJ, Kim MK, Lee TY, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: A prospective study compared with conventional imaging. Am J Gastroenterol. 2008;103:1145-1151
18. Thomas H, Heaton ND. Late recurrence after surgery for cholangiocarcinoma: Implications for follow-up? Hepatobiliary Pancreat Dis Int. 2008;7:544-546